Evidence map›Paper›PMID 27223433›Full record

ArticleOncotarget2016

Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma.

Giancarlo Margheri, Angela Zoppi, Roberto Olmi, Silvana Trigari, Rita Traversi, Mirko Severi, Daniele Bani, Francesca Bianchini, Eugenio Torre, Francesca Margheri and 6 more

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Transient Receptor Potential (TRP) Channels in Tumor Vascularization.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Melanoma treatment: from conventional to nanotechnology.Journal of cancer research and clinical oncology · 2018
    Review
  12. Article
  13. Review
  14. Delivery systems of CRISPR/Cas9-based cancer gene therapy.Journal of biological engineering · 2018
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Giancarlo MargheriInstitute for Complex Systems, National Research Council, Sesto Fiorentino, Italy.
Angela ZoppiDepartment of Physics "Enrico Fermi", University of Pisa, Italy.
Roberto OlmiInstitute of Applied Physics "Nello Carrara", National Research Council, Sesto Fiorentino, Italy.
Silvana TrigariInstitute for Complex Systems, National Research Council, Sesto Fiorentino, Italy.
Rita TraversiDepartment of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy.
Mirko SeveriDepartment of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy.
Daniele BaniDepartment of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
Francesca BianchiniDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Eugenio TorreDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Francesca MargheriDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Anastasia ChillàDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Alessio BiagioniDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Lido CaloriniDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Anna LaurenzanaDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Gabriella FibbiDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
Mario Del RossoDepartment of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the photothermal treatments (PTs) of tumor, the localization of a high number of near-infrared (NIR) absorbing gold nanoparticles in the tumor mass is still a challenging issue. Here, we propose a promising strategy to deliver therapeutic chitosan-coated gold nanoparticles to tumor cells as hidden cargo of Endothelial Colony Forming Cells (ECFCs) endowed with an innate tumor-tropism. Remarkably, ECFC gold enrichement doesn't affect cell viability and preserves the endothelial lineage characteristics such as capillary morphogenesis and cell migration. We demonstrate that heavily Au-doped ECFCs are able to efficiently warm up the tumor environment, and kill the cancer cells via hyperthermic heating both in vitro as well as in vivo. Thus, we show an excellent thermotransductive property of gold enriched ECFCs and their capability to kill melanoma cells at moderate NIR light intensities.

Indexed as

AnimalsCell MovementCell SurvivalChitosanColloidsEndothelial CellsFemaleGoldHumansIonsLightMelanomaMetal NanoparticlesMiceMice, NudeNeoplasm InvasivenessChitosanColloidsCXCR4 protein, humanGoldIonsReceptors, CXCR4chemokine (C-X-C motif) receptor 4 (CXCR4)endothelial colony forming cells (ECFCs)gold nanoparticlesmelanomatumor thermoablation

Identifiers

PMID27223433
PMCPMC5129975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.